Companies: 10,795·Total market cap: $144.5T
Dynavax Technologies Corporation

Dynavax Technologies Corporation

DVAXNASDAQHealthcare
$15.50
+$0.00(+0.00%)
Market Cap$1.8B
P/E Ratio
52W High$15.73
52W Low$9.2
Overview

Dynavax Technologies Corporation (DVAX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

dvax · stock forecast · 11 analysts (3M) · FMP · updated Mar 26, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
1
Sell
1
Strong Sell
0
Total: 11 · Buy rate: 81.8%

12-Month Price Target

High

$32.00

Consensus

$27.00

+74.2% upside

Low

$20.00

Median: $29 · Last Close: $15.50

The Dynavax Technologies Corporation (DVAX) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month DVAX price target is $27.00, representing +74.2% upside from the current price of $15.50.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $27 (74.2%)

Consensus Target

$27.00

74.2% upside

High Target

$32

106.5%

Low Target

$20

29.0%

Current Price

$15.50

as of today

Based on analyst price targets, the DVAX stock price prediction for the next 12 months ranges from $20 to $32. The consensus DVAX price forecast of $27.00 implies 74.2% upside from the current price of $15.50.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$15.500.00%

1-day model range: $15.49–$15.51. Peak: $15.51 (+0.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$18+13.7%
2028$19+22.2%
2029$20+27.3%
2030$20+30.2%
2031+31.8%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

86%7%7%
12Buy
1Neutral
1Sell
RSI (14)20.0Oversold
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · DVAX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$15.50NEUTRAL
MA 10$15.49BUY
MA 20$15.55SELL
MA 50$13.85BUY
MA 100$12.12BUY
MA 200$11.24BUY
Current $DVAX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$15.50BUY
EMA 10$15.50BUY
EMA 20$15.33BUY
EMA 50$14.19BUY
EMA 100$12.96BUY
EMA 200$12.13BUY
Current $DVAX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
William Blair2025-12-24
Downgrade ↓
OutperformMarket Perform
JMP Securities2025-08-22
Maintains
Market OutperformMarket Outperform
JMP Securities2025-08-08
Maintains
Market OutperformMarket Outperform
JMP Securities2025-05-07
Maintains
Market OutperformMarket Outperform
Goldman Sachs2025-04-17
Maintains
SellSell
Citizens Capital Markets2025-02-21
Maintains
Market OutperformMarket Outperform
HC Wainwright & Co.2025-02-21
Maintains
BuyBuy
Goldman Sachs2025-02-11
Downgrade ↓
NeutralSell
HC Wainwright & Co.2025-01-14
Maintains
BuyBuy
HC Wainwright & Co.2024-11-08
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Dynavax Technologies Corporation (DVAX) stock. Of the recent 59 rating actions, 5 were upgrades and 7 were downgrades. 11 analysts currently cover DVAX.

Analyst Recommendation Trends

Buy ratings101
Hold ratings01↑ +1
Sell ratings00

DVAX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$340M

↓ 21.0% YoY

Revenue Next Year

$380M

↑ 11.7% YoY

EPS This Year

$-0.31

EPS Next Year

$0.49

↓ 259.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast DVAX EPS of $-0.31 for the current fiscal year, based on estimates from 2 analysts. The DVAX revenue forecast is $340M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The DVAX stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DVAX price target is $27.00 (+74.2% upside), with an analyst consensus of Buy.

The DVAX short-term stock prediction for tomorrow is $15.50 (+0.00%). The DVAX stock price prediction for 2027 estimates an average of $18. The DVAX stock prediction for 2030 projects a range of $20–$20.

Dynavax Technologies Corporation trades on NASDAQ under the ticker DVAX. The DVAX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

DVAX forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month DVAX price target is $27.00, with a high forecast of $32.00 and a low of $20.00. The median price target is shown in the chart above when available. This implies +74.2% potential upside from the current price of $15.50.

DVAX price targetWhat is DVAX price targetDVAX analyst price targetDVAX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.